Work

Abstract 4512: Impact of clinical response and treatment tolerability on HRQoL in patients treated with ponatinib or imatinib for newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4512

Authors: Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Vanderson Rocha, Cristina Papayannidis, Jessica T. Leonard, Maria R. Baer, Jose-Maria Ribera, James McCloskey, Yanyu Wu, Meliessa Hennessy, Alexander Vorog, Shien Guo

Institutions: City Of Hope National Medical Center, Hospital Universitari i Politècnic La Fe, University of Alabama at Birmingham, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Istituto di Ematologia di Bologna, Oregon Health & Science University, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Josep Carreras Leukaemia Research Institute, Hackensack University Medical Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409626422

Cites:

Cited by:

Related to: 10